Over 20 million podcasts, powered by
1k
900
))
Welcome to the first episode of BackTable Tumor Board, and our first recording session at our new in-person studio! Guest host Dr. Tyler Sandow (interventional radiologist) leads a multidisciplinary discussion about patient care coordination in hepatocellular carcinoma (HCC) diagnosis and treatment, with insights from his colleagues at Ochsner Health– Dr. Steven Young (hepatologist), Dr. Jonathan Mizrahi (medical oncologist), and Deondra Bonds-Adams (patient navigator).
---
This podcast is supported by an educational grant from:
AstraZeneca
https://www.astrazeneca.com/our-therapy-areas/oncology.html
With additional support from:
Boston Scientific
https://www.bostonscientific.com/en-US/medical-specialties/interventional-radiology/interventional-oncology.html
---
SYNPOSIS
The team speaks on the value of having multiple specialties weigh in on treatment conversations that are tailored to each patient’s medical history and risk factors, such as underlying cirrhosis and portal hypertension. Deondra highlights the importance of assessing the patient’s understanding of their disease and the role of physician extenders and schedulers in patient education. Dr. Young discusses the value of outreach clinics and streamlining the transplant evaluation process. Finally, Dr. Mizrahi gives advice on building referral networks and establishing early contact with transplant centers.
---
TIMESTAMPS
00:00 - Introduction
00:46 - Multidisciplinary Tumor Board
06:00 - Patient Experience in Treatment Pathways
10:10 - Barriers to Treatment
16:03 - Benefits of IR Clinic
19:33 - HCC Screening and Risk Factors
24:08 - Building Referral Networks
30:34 - Strategies for Effective Scheduling
35:43 - The Future of HCC Treatment
550 episodes
Welcome to the first episode of BackTable Tumor Board, and our first recording session at our new in-person studio! Guest host Dr. Tyler Sandow (interventional radiologist) leads a multidisciplinary discussion about patient care coordination in hepatocellular carcinoma (HCC) diagnosis and treatment, with insights from his colleagues at Ochsner Health– Dr. Steven Young (hepatologist), Dr. Jonathan Mizrahi (medical oncologist), and Deondra Bonds-Adams (patient navigator).
---
This podcast is supported by an educational grant from:
AstraZeneca
https://www.astrazeneca.com/our-therapy-areas/oncology.html
With additional support from:
Boston Scientific
https://www.bostonscientific.com/en-US/medical-specialties/interventional-radiology/interventional-oncology.html
---
SYNPOSIS
The team speaks on the value of having multiple specialties weigh in on treatment conversations that are tailored to each patient’s medical history and risk factors, such as underlying cirrhosis and portal hypertension. Deondra highlights the importance of assessing the patient’s understanding of their disease and the role of physician extenders and schedulers in patient education. Dr. Young discusses the value of outreach clinics and streamlining the transplant evaluation process. Finally, Dr. Mizrahi gives advice on building referral networks and establishing early contact with transplant centers.
---
TIMESTAMPS
00:00 - Introduction
00:46 - Multidisciplinary Tumor Board
06:00 - Patient Experience in Treatment Pathways
10:10 - Barriers to Treatment
16:03 - Benefits of IR Clinic
19:33 - HCC Screening and Risk Factors
24:08 - Building Referral Networks
30:34 - Strategies for Effective Scheduling
35:43 - The Future of HCC Treatment
550 episodes
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.
1k900
Share
